Abstract
Drug patents are an important aspect of academic and industrial collaboration in drug discovery, including innovation of new drug candidates, the procedure of receiving granted patents of new drugs, and protecting them in the market and courts. The Microperspective considers various modes of collaboration between academics and industry: classic and nonclassic modes of academic patent licensing to the industry, academics used in patent litigations as expert witnesses, assessors, and amicus briefs.
| Original language | English |
|---|---|
| Pages (from-to) | 36-43 |
| Number of pages | 8 |
| Journal | ACS Medicinal Chemistry Letters |
| Volume | 17 |
| Issue number | 1 |
| DOIs | |
| State | Published - 8 Jan 2026 |
Bibliographical note
Publisher Copyright:© 2025 American Chemical Society
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 9 Industry, Innovation, and Infrastructure
Keywords
- Amicus Brief
- Assessor
- Drug Discovery
- Expert Witness
- Insulin
- Lyrica
- Patent
- Person Skilled in the art
- Xtandi
Fingerprint
Dive into the research topics of 'Perspectives of Patents in Academic and Industrial Collaborations in Drug Discovery'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver